FDA okays Jakafi, first drug for rare marrow disease Comments Off on FDA okays Jakafi, first drug for rare marrow disease 131 Views At monthly cost of $7,000, costly new medicine aimed at estimated 20,000 Americans who have myelofibrosis Read More »
Philippe Matthews Show Guru Advice, Author Reviews, Tech Reviews, Entertainment News
